Falta MT, Bowerman NA, Dai S, Kappler JW, and Fontenot AP. Linking Genetic Susceptibility and T Cell Activation in Beryllium-Induced Disease. Proc. Am. Thorac. Soc. In press.
Dai S, Murphy GA, Crawford F, Mack DG, Falta MT, Marrack P, Kappler JW and Fontenot AP. Crystal structure of HLA-DP2: Implications for chronic beryllium disease. Proc. Natl. Acad. Sci. USA. In press.
Mack DG, Lanham AM, Falta MT, Palmer BE, Maier LA and Fontenot AP. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects. Am. J. Respir. Crit. Care Med. In press.
Falta MT and Fontenot AP. Antigen Processing and Presentation. Comprehensive Toxicology 2nd Edition. Volume 6 - Toxicology of the Immune System. Editor D.A. Lawrence.
Falta MT, Fontenot AP, Rosloniec EF, Crawford F, Roark CL, Bill J, Marrack P, Kappler J and Kotzin BL. MHC class II/peptide tetramer staining in relation to functional avidity and TCR diversity in the mouse CD4+ T cell response to a rheumatoid arthritis associated antigen. Arthritis Rheum. 2005; 52:1885-1896.
Sullivan AK, Simonian PL, Falta MT, Cosgrove GP, Brown KK, Kotzin BL, Voelkel NF and Fontenot AP. Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2005; 172:590-596.
Bill JR, Mack DG, Falta MT, Maier LA, Joslin FG, Martin AK, Freed BM, Kotzin BL and Fontenot AP. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II b-chain. J. Immunol. 2005. 175:7029-7037.